Genetic Mutations that Protect Against Alzheimer's Disease

Last fact-checked and updated: October 12, 2026 | Published: January 30, 2025

Key takeaways:

Alzheimer’s disease is a scary possibility that faces many of us today — whether for ourselves or for aging parents or grandparents.
Genetic variants can increase or decrease your risk for Alzheimer’s disease. This article focuses on the variants and rare mutations that protect against Alzheimer’s.
Understanding the pathways that are impacted by protective variants can help us understand possible prevention methods.

Genetic variants that protect against Alzheimer’s disease:

Currently, 10% of people age 65 or older have Alzheimer’s disease (AD), and the risk for Alzheimer’s disease increases considerably with age. It is a disease for which prevention needs to start decades before the symptoms appear.[ref]

This article focuses on the protective side of the equation, something many people worrying about AD fail to consider. While some genetic variants increase the relative risk of AD, other mutations can protect against the disease.

How can genetic variants protect against Alzheimer’s disease?

Not all genetic mutations are harmful. Some change the way a protein works in ways that lower disease risk. Others influence how much of a protein the body produces or how cells process it. In Alzheimer’s disease, protective variants can reduce amyloid-beta production, improve protein clearance, or alter pathways involved in brain inflammation and tau accumulation.[ref] Some variants help prevent Alzheimer’s-related changes from developing, while others may help the brain maintain cognitive function despite those changes. Researchers distinguish these as resistance to disease pathology and resilience against its effects. Neither necessarily means complete immunity from Alzheimer’s.[ref]

The genes below are covered in your genotype report, and they highlight several of the brain’s natural defense pathways. Some contain rare mutations with substantial protective effects, while others contain common variants associated with more modest reductions in risk. Importantly, finding a protective association does not always establish exactly how the variant works, but it gives researchers a good starting point.

APP: Reducing amyloid-beta production

The APP gene encodes amyloid precursor protein, which can be cut by enzymes to produce amyloid-beta. Certain APP mutations significantly increase early-onset Alzheimer’s risk, but the rare A673T variant, often called the Icelandic mutation, does the opposite. It makes APP less susceptible to cutting by the enzyme BACE1, which reduces amyloid-beta production. [ref]

APOE: Changing lipid transport and protein handling

The APOE gene encodes apolipoprotein E, a protein involved in transporting lipids and regulating amyloid-beta accumulation and clearance in the brain. Its three common forms—ε2, ε3, and ε4—have different effects on Alzheimer’s risk. While ε4 increases risk, ε2 generally lowers it and is associated with less Alzheimer’s-related pathology. Proposed protective mechanisms include slower amyloid-beta aggregation and more efficient degradation and clearance.[ref]

Rare APOE variants can also provide protection through mechanisms that are not identical to those of ε2. For example, the APOE Christchurch variant has been associated with delayed cognitive impairment, less tau accumulation, and less damage to brain blood vessels in people carrying an inherited Alzheimer’s-causing mutation. So it is protective only in relation to increased risk from the APOE E4 or familial AD mutations. [ref]

RAB10: Altering the movement and processing of proteins

The RAB10 gene helps regulate the movement of materials within cells, which influences where APP encounters the enzymes that cut it into amyloid-beta. Researchers identified a rare RAB10 variant associated with lower Alzheimer’s risk, and experiments showed that reducing RAB10 expression lowered production of amyloid-beta 42 and the ratio of amyloid-beta 42 to amyloid-beta 40. These findings point to intracellular protein trafficking as a potential protective pathway, although the exact effect of the human variant remains under investigation.[ref]

HMGCR: Modifying cholesterol synthesis

The HMGCR gene encodes a key enzyme in cholesterol production. A variant in this gene influences RNA splicing—the process that determines which sections of a gene’s instructions are included in the final message used to make a protein. This can change the balance between full-length HMGCR and a version missing part of its enzyme-related region. Some studies associate this variant with lower Alzheimer’s risk or delayed progression, suggesting that cholesterol regulation may affect vulnerability to the disease. The findings do not establish that lowering blood cholesterol reproduces the variant’s effects in the brain.pmc.ncbi.nlm.nih+1

MAPT: Influences tau

The MAPT gene encodes tau, a protein that normally helps stabilize the internal framework of neurons. In Alzheimer’s disease, abnormal tau accumulates in tangles that impede brain function. Common inherited patterns of variation around MAPT, called haplotypes, have been linked to differences in neurodegenerative disease risk. The H2 haplotype has been associated with lower Alzheimer’s risk in some studies and influences how tau RNA is spliced.[ref]

ZCWPW1: A protective genetic region with an unresolved mechanism

The ZCWPW1 gene encodes a protein that recognizes chemical marks on histones, which are the proteins around which DNA is packaged. This is part of epigenetic regulation, controlling which genes are turned on or off. A common variant in this region is associated with a modest reduction in Alzheimer’s risk.[ref]

CLU: Helping handle proteins outside cells

The CLU gene encodes clusterin, also known as apolipoprotein J. Clusterin participates in the handling of proteins outside cells and has been implicated in amyloid-beta deposition and clearance. Common variants near CLU are associated with differences in Alzheimer’s risk, suggesting that changes in this protein-handling pathway may influence whether amyloid-beta accumulates. However, the association does not mean that every protective CLU variant has a fully established mechanism.[ref]

PICALM: Supporting cellular transport and amyloid clearance

The PICALM gene helps cells package and move materials through small membrane-bound compartments. In Alzheimer’s research, PICALM has been linked to APP processing, amyloid-beta transport across the blood-brain barrier, and pathways affecting tau pathology. Protective variants near PICALM point to the importance of the brain’s transport and disposal systems: Alzheimer’s risk depends not only on how much amyloid-beta is produced, but also on how effectively it is moved and cleared.[ref]

DAB1: Relaying signals that support neurons

The DAB1 gene encodes a signaling protein inside neurons that responds to reelin, a protein involved in brain development and neuronal function. This pathway can suppress an enzyme involved in abnormal tau phosphorylation—the addition of chemical groups that can contribute to tau dysfunction. DAB1 also interacts with APP and can influence its processing. A genetic study in people with two copies of APOE ε4 identified a protective association near DAB1, suggesting that reelin–DAB1 signaling may modify the risk associated with APOE ε4.[ref]

FN1: Limiting excess fibronectin around brain blood vessels

The FN1 gene encodes fibronectin, a structural protein found in the material surrounding cells, including at the blood-brain barrier. Researchers found more fibronectin at this barrier in APOE ε4 carriers who developed Alzheimer’s than in carriers who remained unaffected. Rare FN1 variants associated with protection suggest that limiting excess fibronectin buildup may help preserve a healthier environment around brain blood vessels. The strongest reported protective association was identified in people with two copies of APOE ε4, making genetic background an important part of interpreting this finding. Related article: Fibronectin and Alzheimer’s prevention

RELN: Strengthening a pathway linked to cognitive resilience

The RELN gene encodes reelin, a protein that helps organize the developing brain and activates signaling pathways in mature neurons. Reelin works through receptors that recruit DAB1, connecting these two genes within the same pathway. Experimental evidence links this signaling to APP processing and regulation of enzymes involved in tau phosphorylation.[ref]

Alzheimer’s Protection Genotype Report:

APP gene: Early-onset or familial Alzheimer’s occurs before the age of 65. Researchers discovered almost 50 mutations in the APP gene that cause early-onset Alzheimer’s. But – Not all APP mutations are bad. Researchers discovered an APP mutation, called the APP A673T mutation (commonly known as the Iclelandic Mutation), that is protective against getting Alzheimer’s. Less than 0.1% of the population carries this rare variant. The mutation is more common in people from Iceland, Norway, and Sweden.

Access this content:

An active subscription is required to access this content.

Lifehacks for preventing Alzheimer’s:

There are currently no medications for curing Alzheimer’s disease, and research shows that preventative actions need to start decades before the onset of the disease.

Download my free eBook on Alzheimer’s prevention

Circadian rhythm, Sleep, and Light at Night:
I’ve written before on the links between circadian rhythm disruption and Alzheimer’s disease as well as other lifehacks that may help with prevention.

Cholesterol:
Lower cholesterol levels may decrease the risk of Alzheimer’s. This protective effect comes from having lower cholesterol throughout life. People who carry certain PCSK9 variants have lower lifetime cholesterol and possibly half the risk of Alzheimer’s.[ref]

Research isn’t clear on what the magic level of cholesterol is for Alzheimer’s. This is something to consider when adopting a ketogenic diet high in saturated fat, which may cause an increase in cholesterol. Some people argue that there is no need to worry when their cholesterol level rises with a high-fat diet. The link between cholesterol and cardiovascular disease may have some questions surrounding it, but the link between Alzheimer’s and cholesterol is something to consider as well.